The Retina Illustrated

449 Pages·2019·27.476 MB·English

by  Justis P. Ehlers

TPS23x31-2|18.09.19-11:25
TPS23x31-2|18.09.19-11:25
TPS23x31-2|18.09.19-11:25
The Retina Illustrated
Justis P. Ehlers, MD
The Norman C. and Donna L. Harbert Endowed Chair for Ophthalmic Research
Director, The Tony and Leona Campane Center for Excellence in Image-Guided Surgery and
Advanced Imaging Research
Cole Eye Institute
Cleveland Clinic
Cleveland, Ohio
Assistant Editor
Thuy K. Le, BA
Project Lead, The Tony and Leona Campane Center for Excellence in Image-Guided Surgery
and Advanced Imaging Research
Cole Eye Institute
Cleveland Clinic
Cleveland, Ohio
407 illustrations
Thieme
New York (cid:129) Stuttgart (cid:129) Delhi (cid:129) Rio de Janeiro
TPS23x31-2|18.09.19-11:25
LibraryofCongressCataloging-in-PublicationData Importantnote:Medicineisanever-changingscienceundergo-
ingcontinualdevelopment.Researchandclinicalexperienceare
Names:Ehlers,JustisP.,editor.
continuallyexpandingourknowledge,inparticularourknowl-
Title:Theretinaillustrated/[editedby]JustisP.Ehlers.
edgeofpropertreatmentanddrugtherapy.Insofarasthisbook
Description:NewYork:Thieme,[2020]|Includesbibliographical
mentionsanydosageorapplication,readersmayrestassuredthat
referencesandindex.
Identifiers:LCCN2019034798(print)|LCCN2019034799(ebook) the authors, editors, and publishers have made every effort to
ensurethatsuchreferencesareinaccordancewiththestateof
|ISBN9781626238312(paperback)|ISBN9781626238336
knowledgeatthetimeofproductionofthebook.
(ebook)
Subjects:MESH:RetinalDiseases–diagnosticimaging|Retinal Nevertheless, this does not involve, imply, or express any
Diseases–surgery guaranteeorresponsibilityonthepartofthepublishersinrespect
Classification:LCCRE551(print)|LCCRE551(ebook)|NLMWW toanydosageinstructionsandformsofapplicationsstatedinthe
270|DDC617.7/35–dc23 book.Everyuserisrequestedtoexaminecarefullythemanufac-
turers’leafletsaccompanyingeachdrugandtocheck,ifnecessary
LCrecordavailableathttps://lccn.loc.gov/2019034798
inconsultationwithaphysicianorspecialist,whetherthedosage
LCebookrecordavailableathttps://lccn.loc.gov/2019034799
schedulesmentionedthereinorthecontraindicationsstatedbythe
manufacturers differ from the statements made in the present
book.Suchexaminationisparticularlyimportantwithdrugsthat
areeitherrarelyusedorhavebeennewlyreleasedonthemarket.
Everydosagescheduleoreveryformofapplicationusedisentirely
attheuser’sownriskandresponsibility.Theauthorsandpublishers
requesteveryusertoreporttothepublishersanydiscrepanciesor
inaccuraciesnoticed.Iferrorsinthisworkarefoundafterpubli-
cation,erratawillbepostedatwww.thieme.comontheproduct
descriptionpage.
Someoftheproductnames,patents,andregistereddesigns
referredtointhisbookareinfactregisteredtrademarksorpro-
prietarynameseventhoughspecificreferencetothisfact isnot
always made in the text. Therefore, the appearance of a name
without designation as proprietary is not to be construed as a
Copyright©2020byThiemeMedicalPublishers,Inc.
representationbythepublisherthatitisinthepublicdomain.
ThiemePublishersNewYork
333SeventhAvenue,NewYork,NY10001USA
[phone],[email protected]
ThiemePublishersStuttgart
Rüdigerstrasse14,70469Stuttgart,Germany
+49[0]7118931421,[email protected]
ThiemePublishersDelhi
A-12,SecondFloor,Sector-2,Noida-201301
UttarPradesh,India
[phone],[email protected]
ThiemeRevinterPublicaçõesLtda.
RuadoMatoso,170–Tijuca
RiodeJaneiroRJ20270-135-Brasil
[phone]
www.thiemerevinter.com.br
Coverdesign:ThiemePublishingGroup
TypesettingbyThomsonDigital,India
PrintedintheUnitedStatesofAmerica This book, including all parts thereof, is legally protected by
byKingPrintingCo.,Inc. 54321 copyright.Anyuse,exploitation,orcommercializationoutsidethe
narrowlimitssetbycopyrightlegislation,withoutthepublisher’s
ISBN978-1-62623-831-2 consent, is illegal and liable to prosecution. This applies in
particular to photostat reproduction, copying, mimeographing,
Alsoavailableasane-book: preparation of microfilms, and electronic data processing and
eISBN978-1-62623-833-6 storage.
TPS23x31-2|18.09.19-11:25
Tomyparentsforshowingmehowtofollowmydreams.
Tomywonderfulwife,Gina,andmytwoamazingchildren,AdelynandCooper,
forenablingmetolivethosedreamseverydaywitheachofyou.
TPS23x31-2|18.09.19-11:25
TPS23x31-2|18.09.19-11:25
Contents
Preface .................................................................................................... xv
Acknowledgments....................................................................................... xvi
Contributors.............................................................................................. xvii
Part I Retinal Diagnostics
1 OpticalCoherenceTomography..................................................................... 2
RachelC.ChenandPeterK.Kaiser
2 FluoresceinAngiography ............................................................................ 6
JeremyA.LavineandJustisP.Ehlers
3 IndocyanineGreenAngiography.................................................................... 9
DanielR.AgarwalandSumitSharma
4 OpticalCoherenceTomographyAngiography..................................................... 13
MalvikaAryaandNadiaK.Waheed
5 IntraoperativeOpticalCoherenceTomography ................................................... 18
AtsuroUchidaandJustisP.Ehlers
6 FundusAutofluorescence............................................................................ 22
SriniVasSaddaandEnricoBorrelli
Part II Macular and Peripheral Vitreoretinal Interface Disorders
7 PosteriorVitreousDetachment..................................................................... 28
NataliaAlbuquerqueLucenaFigueiredoandJustisP.Ehlers
8 EpiretinalMembrane................................................................................. 31
RaminTadayoni
9 MacularHoles......................................................................................... 35
PhilipP.StoreyandCarlD.Regillo
10VitreomacularTraction .............................................................................. 39
AlmyrS.Sabrosa,DanielaFerrara,andJayS.Duker
11RetinalTearsandHoles.............................................................................. 43
VishalS.Parikh,AnjaliShah,andGauravK.Shah
12PrimaryRhegmatogenousRetinalDetachment................................................... 46
PriyaSharmaandChiragShah
13GiantRetinalTear..................................................................................... 52
DanielSuandAllenHo
14RetinalDialysis........................................................................................ 55
MaxwellS.StemandJeremyD. Wolfe
vii
TPS23x31-2|18.09.19-11:25
Contents
15ProliferativeVitreoretinopathy..................................................................... 59
JeremyA.LavineandJustisP.Ehlers
16Retinoschisis.......................................................................................... 63
YujiItoh
17LatticeDegeneration................................................................................. 66
JenniferC.W.HuandJustisP.Ehlers
Part III Retinal Vascular Disease
18DiabeticRetinopathyandDiabeticMacularEdema............................................... 70
NataliaAlbuquerqueLucenaFigueiredoandJustisP.Ehlers
19RetinalVeinOcclusion ............................................................................... 77
SharonFekratandMohsinH.Ali
20RetinalArteryOcclusion............................................................................. 82
RishiP.SinghandAngLi
21OcularIschemicSyndrome.......................................................................... 86
TaliaR.KadenandYashaS.Modi
22RetinalArterialMacroaneurysm.................................................................... 89
KevinWangandJustisP.Ehlers
23RadiationRetinopathy............................................................................... 92
PeterH.TangandPrithviMruthyunjaya
24SickleCellRetinopathy .............................................................................. 96
PaulE.IsraelsenandAndrewW.Browne
25HypertensiveRetinopathy........................................................................... 100
MarisaK.LauandPaulaEemPecen
Part IV Retinal Degenerations and Dystrophies
26DryAge-RelatedMacularDegeneration ........................................................... 106
SruthiArepalliandAndrewP.Schachat
27WetAge-RelatedMacularDegeneration........................................................... 110
JenniferC.W.HuandJustisP.Ehlers
28PolypoidalChoroidalVasculopathy................................................................. 116
KeikoKataokaandHirokoTerasaki
29Age-RelatedChoroidalAtrophy..................................................................... 121
RichardF.Spaide
30MyopicDegenerationandMyopicFoveoschisis................................................... 125
MakotoInoueandYujiItoh
31AngioidStreaks....................................................................................... 130
RobertJ.Courtney
viii
TPS23x31-2|18.09.19-11:25
Contents
32BestDisease........................................................................................... 134
DanielR.AgarwalandEliasI.Traboulsi
33AdultVitelliformMacularDystrophy............................................................... 139
MatthewR.StarrandSophieJ.Bakri
34PatternDystrophy.................................................................................... 142
AmyS.BabiuchandEliasI.Traboulsi
35MacularTelangiectasia............................................................................... 147
S.AmalHussnainandYashaS.Modi
36RetinitisPigmentosa ................................................................................. 151
MeghanJ.DeBenedictisandAleksandraRachitskaya
37ConeDystrophy....................................................................................... 157
HuberMartinsVasconcelos,Jr.andPaulYang
38ParaneoplasticRetinopathies........................................................................ 162
OmarS.PunjabiandDilrajGrewal
39CongenitalStationaryNightBlindness............................................................. 166
LaryssaA.Huryn,BrettG.Jeffrey,andCatherineA.Cukras
40Albinism............................................................................................... 169
AtalieC.ThompsonandLejlaVajzovic
41GyrateAtrophy ....................................................................................... 173
MatteoScaramuzziandEliasI.Traboulsi
42Choroideremia........................................................................................ 179
RubenJaureguiandStephenH.Tsang
43StargardtDisease..................................................................................... 182
SruthiArepalliandJustisP.Ehlers
44CobblestoneDegeneration.......................................................................... 186
KevinWangandJustisP.Ehlers
Part VOther Macular Disorders
45CentralSerousChorioretinopathyandPachychoroidDisease ................................... 190
BelindaC.S.LeongandK.BaileyFreund
46HypotonyMaculopathy.............................................................................. 196
NathanE.CutlerandJustisP.Ehlers
47CystoidMacularEdema.............................................................................. 199
NandiniVenkateswaranandJayanthSridhar
48ChoroidalFolds ....................................................................................... 202
JayaB.KumarandJustisP.Ehlers
ix